Despite positive recommendations, MSD maintains Welireg should have been subject to NICE's appraisal process for very rare disease treatments • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
